Sodium-Hydrogen Exchanger 3 Inhibitor [EPC] - N0000194056

Pharmacologic Code	N0000194056
Pharmacologic Name	Sodium-Hydrogen Exchanger 3 Inhibitor
Pharmacologic Uses	sodium/hydrogen exchanger 3 (NHE3) inhibitor
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

The table contains 4 products whose active ingredient are classified under the same pharmacologic class Sodium-Hydrogen Exchanger 3 Inhibitor [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	73154-050	Ibsrela	Non-Proprietary Name: Tenapanor Hydrochloride	Tablet	Oral	Ardelyx, Inc.	ACTIVE
	73154-110	Xphozah 10 Mg	Non-Proprietary Name: Tenapanor	Tablet, Film Coated	Oral	Ardelyx, Inc.	ACTIVE
	73154-120	Xphozah 20 Mg	Non-Proprietary Name: Tenapanor	Tablet, Film Coated	Oral	Ardelyx, Inc.	ACTIVE
	73154-130	Xphozah 30 Mg	Non-Proprietary Name: Tenapanor	Tablet, Film Coated	Oral	Ardelyx, Inc.	ACTIVE